Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GW438014A
Cat. No.:
OB0425LY-032
Appearance:
Solid
Purity:
99.98%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
GW438014A is a novel anti-obesity drug molecule with a unique mechanism of action.
Synonyms:
469861-49-2; N-[1-(2-Phenylethyl)-1H-benzimidazol-2-yl]benzamide; N-[1-(2-Phenylethyl)benzimidazol-2-yl]benzamide; GW-438014A
CAS No.:
469861-49-2
Compound CID:
6918627
Formula:
C23H23N3O4S
Formula Weight:
437.51
Specification
Target:
Neuropeptide Y receptor
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
GW438014A can be applied to assess its effects on weight loss and metabolic syndrome.
